ATRIX LABORATORIES INC
10-Q, EX-27, 2000-11-01
PHARMACEUTICAL PREPARATIONS
Previous: ATRIX LABORATORIES INC, 10-Q, EX-10.13, 2000-11-01
Next: SOUTHWEST ROYALTIES INSTITUTIONAL INCOME FUND VII-B L P, 10-Q, 2000-11-01



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       8,213,184
<SECURITIES>                                28,110,336
<RECEIVABLES>                                2,568,486
<ALLOWANCES>                                    50,305
<INVENTORY>                                  2,240,347
<CURRENT-ASSETS>                            42,551,668
<PP&E>                                      11,094,144
<DEPRECIATION>                               4,354,012
<TOTAL-ASSETS>                              54,179,240
<CURRENT-LIABILITIES>                        3,004,123
<BONDS>                                     36,190,000
                                0
                                         12
<COMMON>                                        12,462
<OTHER-SE>                                  14,972,643
<TOTAL-LIABILITY-AND-EQUITY>                54,179,240
<SALES>                                      4,587,785
<TOTAL-REVENUES>                             5,950,869
<CGS>                                        1,933,261
<TOTAL-COSTS>                               17,108,954
<OTHER-EXPENSES>                          (12,035,025)
<LOSS-PROVISION>                                50,305
<INTEREST-EXPENSE>                           1,941,260
<INCOME-PRETAX>                           (23,636,534)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (23,636,534)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                 79,906
<CHANGES>                                            0
<NET-INCOME>                              (23,727,142)
<EPS-BASIC>                                     (2.03)
<EPS-DILUTED>                                   (2.03)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission